Agilent Investments

Agilent has invested in 34 companies and its latest investment was RareCyte on Jun 26, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

RareCyte is a Washington-based precision biology company that develops and markets spatial and liquid biopsy systems and software products for the life sciences industry.
$20M
Jun 26, 2024
-
Elegen is a California-based SaaS platform that provides solutions such as DNA production and clinical manufacturing for the pharmaceutical sector.
$35M
May 14, 2024
-
Biofidelity is an England-based genomic technology company that develops and markets biomarkers and reagents for physicians, biopharma companies and lab directors.
$24M
Apr 02, 2024
-
Halo Labs is a California-based life science instrumentation firm that develops biopharmaceutical formulation and quality control devices for the healthcare sector.
$6M
Jul 10, 2022
-
Arima Genomics is a California-based biotechnology company that researches and develops genome sequencing kits for healthcare organizations.
$7M
Mar 14, 2022
-

Frequently Asked Questions about Agilent

  1. What is Agilent investing in?

    Agilent has invested in 34 companies including RareCyte, Elegen and Biofidelity
  2. What company did Agilent invest in?

    Agilent invested in a total 34 companies including RareCyte, Elegen and Biofidelity
  1. What are the top 5 investments by Agilent?

    The top companies in which Agilent invested are RareCyte, Elegen, Biofidelity, Halo Labs and Arima Genomics